发明名称 INHIBITION OF MARCKS-MEDIATED DEGRANULATION BY MARCKS N-TERMINAL PEPTIDES IN TREATING INFLAMMATION
摘要 The present invention includes methods of inhibiting or suppressing cellular secretory processes. More specifically the present invention relates to inhibiting or reducing the release of inflammatory mediators from inflammatory cells by inhibiting the mechanism associated with the release of inflammatory mediators from granules in inflammatory cells. In this regard, the present invention discloses an intracellular signaling mechanism that illustrates several novel intracellular targets for pharmacological intervention in disorders involving secretion of inflammatory mediators from vesicles in inflammatory cells. Peptide fragments and variants thereof of MANS peptide as disclosed in the present invention are useful in such methods. The present invention also discloses MARCKS protein and the inhibition of MARCKS-mediated degranulation to prevent release of inflammatory mediators by N-terminal peptides of MARCKS.
申请公布号 CA2842219(A1) 申请公布日期 2008.01.31
申请号 CA20072842219 申请日期 2007.07.26
申请人 BIOMARCK PHARMACEUTICALS, LTD. 发明人 PARIKH, INDU
分类号 A61K38/17;A61K9/72;A61P11/00;A61P29/00 主分类号 A61K38/17
代理机构 代理人
主权项
地址